| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,502,800 | 3,664,100 | 3,988,000 | 3,964,800 | | Cost of Revenue | 1,490,400 | 1,613,500 | 1,751,800 | 1,725,000 | | | Gross Profit | 2,012,400 | 2,050,600 | 2,236,200 | 2,239,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,201,000 | 1,258,300 | 1,415,400 | 1,395,500 | | Non Recurring |
-
| 24,000 | (77,300) | 77,300 | | Others |
-
| 18,800 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 811,400 | 749,500 | 898,100 | 767,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 98,600 | (129,700) |
-
| | Earnings Before Interest And Taxes | 811,400 | 771,600 | 768,400 | 767,000 | | Interest Expense | 21,200 | 23,600 | 22,900 | 25,400 | | Income Before Tax | 790,200 | 748,000 | 745,500 | 741,600 | | Income Tax Expense | 253,700 | 251,000 | 245,600 | 247,800 | | Minority Interest | (28,600) | (80,300) |
-
|
-
| | | | Net Income From Continuing Ops | 507,900 | 497,000 | 499,900 | 493,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 507,900 | 497,000 | 499,900 | 493,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $507,900 | $497,000 | $499,900 | $493,800 |
|
0.45% Nasdaq 
0.20%
Income Statement
